LifeVine Wellness puts two accessible-looking numbers in front of prospective weight-management patients: compounded semaglutide starting at $247 per month and compounded tirzepatide starting at $347 per month. But neither figure is a confirmed standalone monthly purchase price. The accompanying explanation calls them estimated monthly equivalents of multimonth plans, with actual pricing determined by the prescribing provider. For someone comparing programs against a household budget, that distinction matters more than the size of the headline number: the advertised equivalent does not establish what will leave your account when you enroll.
This documentary review examines LifeVine’s official materials consulted October 19, 2026, emphasizing payment structure rather than treating a starting price as a complete quote. The documented offering combines online intake, an independent clinician’s evaluation, compounded medication if prescribed, shipping and portal follow-up. Its terms also describe automatic renewals, potentially early charges and limits on refunds. Those features make the service more understandable, but the supplied pages leave the initial payment, multimonth plan length and final patient-specific price unresolved. The practical task is to reconcile the clinical plan with the actual purchase agreement before paying.
At a glance
- Semaglutide starting price
- Compounded subcutaneous semaglutide is advertised from $247 per month as an estimated monthly equivalent of a multimonth plan, not a confirmed month-to-month rate.Sources: [4]
- Tirzepatide starting price
- Compounded subcutaneous tirzepatide is advertised from $347 per month under the same estimated multimonth-plan pricing qualification.
- Advertised inclusions
- Plans include independent clinician evaluation, a personalized plan, medication if prescribed, free discreet shipping and ongoing care-team portal messaging.Sources: [9]
- Renewal and cancellation
- Subscription charges recur at checkout-disclosed intervals. Cancellation must occur at least two days before renewal processing; partially used periods generally are not refundable.Sources: [2]
Start with the amount due, not the monthly equivalent
The semaglutide and tirzepatide pages describe compounded medications administered at home by subcutaneous injection. Their advertised starting amounts—$247 and $347 per month, respectively—carry a material qualification: prices are estimates reflecting the monthly equivalent cost of multimonth plans. Actual pricing depends on the prescribing provider, medication and treatment plan. The supplied evidence does not establish a particular vial presentation, supply quantity, final formulation details or patient-specific charge. Nor does it establish that either medicine can be purchased one calendar month at a time for the displayed amount.
The missing number is the first transaction. The pages do not specify the multimonth plan’s duration, total price, initial collection or whether full prepayment is required. A multimonth description alone establishes neither a minimum commitment nor the quantity shipped. There is also no documented introductory discount, promotional code or separate renewal price to compare. Our guide to why the first payment can differ from the advertised monthly price explains the distinction. Here, request a written quote showing the amount collected now, the covered period and each later charge before treating either headline as a budget.
| Item | What the materials establish | What still needs confirmation |
|---|---|---|
| Compounded semaglutide injection | From $247/month; estimated multimonth-plan equivalent | Final price, first payment, plan duration and presentation |
| Compounded tirzepatide injection | From $347/month; estimated multimonth-plan equivalent | Final price, first payment, plan duration and presentation |
| Plan services | Evaluation, personalized plan, medication if prescribed, shipping and portal messaging | Any patient-specific services or charges outside the quoted package |
| Subscription renewal | Automatic charges at intervals disclosed during checkout | Exact processing dates, amounts and any early first renewal |
| Outside pharmacy | Patient obtains the product and pays that pharmacy directly | What platform charges remain and the pharmacy’s separate price |
What the advertised package includes—and where another bill can arise
LifeVine’s operating page says every plan includes an evaluation by an independent licensed clinician, a personalized treatment plan, medication dispensed by a licensed compounding pharmacy if prescribed, free discreet shipping and ongoing messaging through the patient portal. Those are meaningful inclusions when comparing a medication-only quote with a broader care package. The site also says patients can message about questions, treatment adjustments and follow-up without booking another appointment. It does not publish a clinical response deadline in the supplied pages, however, so messaging access should not be read as immediate clinician availability.
The clearest documented exception concerns an outside pharmacy. The terms allow the service to send a prescription to a patient-selected pharmacy, but the patient must obtain the product and pay that pharmacy directly. The record does not explain how choosing that route changes the platform’s package charge. Another boundary concerns an unsuccessful evaluation: LifeVine says patients will not be charged for medication they do not receive, but that is not a promise to refund every other charge. The relevant comparison is what a program price actually includes, followed by written confirmation of any separate evaluation or pharmacy costs.
Renewal timing can matter as much as the renewal amount
LifeVine’s terms say certain products and services require automatically renewing subscriptions. The payment method is charged at the regular intervals disclosed for the purchase during checkout until cancellation. That language does not establish a universal monthly billing cycle, and the public starting-price equivalents do not supply one. The first renewal may be charged early to prevent a treatment interruption; the supplied wording does not state a maximum early window for that first charge. Subsequent renewal charges and applicable shipments may move up by as much as two days for holidays or other operational reasons.
For budgeting, ask for the processing date rather than relying only on a shipment date or an assumed monthly anniversary. A charge and a shipment are different events, and neither establishes arrival. The terms also permit plan and price changes with advance notice, so the public starting amount is not a documented long-term price lock. If LifeVine offers a pause, billing resumes automatically when that pause ends unless the subscription is canceled. A pause is therefore a scheduled interruption, not a permanent exit; its end date belongs alongside the renewal processing date in the purchase record.
Cancellation stops a future period, not necessarily today’s cost
The terms provide several cancellation paths: in the app, through the online account under “My Subscriptions,” by emailing support@lifevinewellness.com or by directly requesting cancellation. Cancellation takes effect at the end of the current subscription period. To avoid another period, the request must be made at least two days before the applicable renewal processing date. That deadline deserves particular attention because the same terms allow early processing. A general statement that a patient can stop the program does not erase the specific notice requirement or turn the current paid period into a refundable purchase.
LifeVine generally does not refund partially used subscription periods, although it reserves discretion to make case-by-case exceptions. A discretionary exception is not a dependable budget assumption. Save the cancellation request and obtain confirmation of its effective date and whether another payment is scheduled. The supplied terms also contain an omitted middle section, limiting a complete contractual review. Our explanation of cancellation and refund boundaries provides context, but LifeVine’s own written confirmation should settle the patient’s actual account status. The evidence does not establish a general refund entitlement or a bank-credit timetable.
Self-pay means more than the platform not billing insurance
LifeVine describes itself as self-pay and says it does not bill Medicare, Medicaid or commercial insurance. Its terms go further: neither the user nor the participating platform, laboratories, pharmacies, medical groups or providers will submit reimbursement claims to public programs or commercial payers for products and services obtained through the service. That makes this more restrictive than simply declining to process insurance paperwork. Someone hoping to pay first and seek reimbursement later should resolve that contractual provision before enrolling rather than assume an ordinary out-of-network reimbursement route is available.
The site says many services are HSA/FSA eligible, but the supplied material does not identify which services or confirm eligibility for a particular purchase. That statement should not be treated as a tax conclusion or as confirmation from an account administrator. Nor does not billing Medicare or Medicaid, by itself, establish that everyone enrolled in those programs is excluded from purchasing. The documented issue is payment and reimbursement. For a practical comparison, insurance and self-pay questions should be considered alongside the final written quote, especially when another program’s medication price and consultation coverage are structured differently.
Follow the money through the platform and clinical practice
LifeVine says it was founded by a nurse in Greensboro, North Carolina, and operates entirely online. Its legal notice draws an important distinction from the marketing description of a health practice: LifeVine is the technology platform, not the healthcare provider, and does not itself provide medical advice, diagnosis or treatment. Clinical services are attributed to Dr Tel X, an independent professional medical practice. The published direct contacts for that network are support@drtelx.com and 1-855-697-5757. This separation helps patients distinguish an account or billing question from a question about the clinician’s decision or care responsibilities.
The process starts with a questionnaire covering health history, current symptoms and goals; LifeVine estimates about ten minutes to complete it. That is not a promise of a ten-minute clinical review. An evaluation by a clinician licensed in the patient’s state follows, asynchronously or by phone or video depending on the case and state requirements. Eligibility is decided individually, not guaranteed by finishing intake. LifeVine’s eligibility page also excludes people who are pregnant, breastfeeding or trying to conceive and says the clinician screens personal and family history for conditions that could make GLP-1 treatment inappropriate. The general contact form advertises a response within a couple of business days, while medical questions belong in the portal. That administrative response estimate does not establish a clinical response time or prescription turnaround.
National availability still has state and delivery conditions
LifeVine advertises availability in all 50 states and Washington, DC, subject to medication-specific rules and professional licensure. It lists asynchronous care in 44 states and requires a live consultation before treatment in DC, Kansas, Louisiana, Mississippi, New Mexico, Rhode Island and West Virginia. The terms require a U.S. resident to be physically in the same state as the account’s shipping address during consultation. The availability provision requires adulthood, including a higher local age of majority where applicable. Although another passage mentions parental consent, the separate adults-only policy means the record should not be read as confirming treatment access for minors.
Shipping is advertised as free, discreet, plain and unbranded, but timelines vary; the care team supplies an estimated delivery time when prescribing. The terms also warn that not all prescriptions are dispensed in child-resistant packaging. The evidence does not establish a carrier, refrigeration protocol, replacement policy or fixed transit window. Refills run through the portal and may require prescriber review; continued prescribing is not guaranteed. LifeVine names EPIQ Scripts, Foothills Pharmacy and Emerald Compounding Pharmacy as partners and claims to use selected U.S.-licensed 503A compounding pharmacies. Those licensing, accreditation and quality assertions were not independently verified, and the supplied pages do not identify which pharmacy would serve a particular patient.
A bundled price does not establish product approval or outcomes
LifeVine explicitly states that its compounded GLP-1 medications are not FDA approved and require a prescription following an individual clinical evaluation. FDA explains that compounded preparations do not undergo its premarket review for safety, effectiveness and quality. Nonapproval alone does not establish clinical inequivalence, but a pharmacy’s claimed quality credentials also do not confer product approval. FDA recommends compounded drugs for patients whose medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy. The appropriate question is why the proposed preparation meets the individual’s needs—not whether the package price makes it equivalent to an approved product.
Delivery and instruction questions remain relevant even when shipping is included. FDA explicitly advises not using an injectable GLP-1 product that arrives warm or inadequately refrigerated and contacting the provider or dispensing pharmacy. It also reports measuring and administration errors with compounded medications, some associated with hospitalization; instructions should be clarified with the prescriber or pharmacist rather than calculated from a review. These are general regulatory concerns, not documented LifeVine incidents. Neither a starting price nor a bundled follow-up service establishes this provider’s clinical outcomes, an individual’s likely results or the suitability of a particular prescription.
Questions & answers
Can I buy one month of LifeVine semaglutide for $247?
The supplied pages do not confirm that option. The $247 starting figure is an estimated monthly equivalent of a multimonth compounded semaglutide plan, with actual pricing determined by the prescriber and treatment plan. The same qualification applies to tirzepatide’s $347 starting figure. Ask for the total plan price, amount due immediately, billing interval and supplied presentation. Do not assume the monthly equivalent is the checkout charge or that the entire plan must be prepaid.
What happens financially if the clinician does not prescribe treatment?
LifeVine says the clinician will explain why treatment is inappropriate and that patients will not be charged for medication they do not receive. That protects against a medication charge in the described situation, but it does not establish that an evaluation or every other service is free or refundable. The supplied evidence does not provide a complete no-prescription fee breakdown. Request that breakdown before authorizing payment, including when any non-medication charge becomes nonrefundable.
How early should I cancel a LifeVine subscription?
The contractual minimum is at least two days before the applicable renewal processing date, not simply before an expected delivery. Cancellation takes effect at the current period’s end. Because the terms allow an early first renewal and subsequent charges up to two days early, obtain the actual processing date from the account or support team. Use the app, “My Subscriptions,” support@lifevinewellness.com or a direct cancellation request, and retain confirmation. Cancellation does not itself create a refund for a partly used period.
Can I use my own pharmacy instead of LifeVine’s partners?
The terms permit sending the prescription to a selected outside pharmacy. In that arrangement, you are responsible for obtaining the prescription product and paying the pharmacy directly. The record does not establish how the change affects LifeVine’s remaining charges or whether the selected pharmacy can supply the prescribed preparation. Confirm both sides of the transaction before paying: the platform’s retained fees and the pharmacy’s product, availability, price and delivery or pickup responsibilities.
Does LifeVine include ongoing follow-up and automatic refills?
Ongoing portal messaging is advertised as included, with access for questions, treatment adjustments and follow-up without another appointment booking. Refills are handled through that portal, but a provider review may be required and continued prescribing is not guaranteed. An automatically renewing payment arrangement is therefore not the same thing as an unconditional prescription renewal. The supplied materials do not give a fixed follow-up schedule, clinical response deadline or universal laboratory requirement.
Does LifeVine offer services beyond GLP-1 weight management?
Its FAQ describes GLP-1 weight management as the current focus and women’s hormone health as in development, not confirmed available. Catalog cards also advertise sermorelin peptide therapy starting at $167 per month, subject to the estimated multimonth-plan-equivalent pricing qualification. A dedicated sermorelin product page was not part of the supplied record, so its detailed terms cannot be assessed here. That catalog listing should not be mistaken for another GLP-1 medicine or a confirmed standalone monthly purchase.
Our assessment
LifeVine documents a useful set of package components: independent clinician evaluation, medication if prescribed, shipping and continuing portal access. It also identifies its clinical practice and pharmacy partners, while acknowledging that its GLP-1 preparations are compounded and not FDA approved. The principal cost limitation is that its most visible prices are estimated multimonth-plan equivalents, not complete purchase offers. A workable decision requires the actual first payment, total covered period, renewal amount and processing date, plus any charges retained after an unsuccessful evaluation or outside-pharmacy choice. The cancellation routes are reasonably explicit, but early renewals and generally nonrefundable partial periods make timing consequential. LifeVine is best evaluated from a written patient-specific quote and subscription schedule—not from $247 or $347 alone. If those details are supplied clearly, the package can be compared meaningfully with alternatives; the public starting figures by themselves do not settle affordability.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.
- FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
- LifeVine Wellness — terms ↗
- LifeVine Wellness — official website ↗
- LifeVine Wellness — semaglutide ↗
- LifeVine Wellness — faq ↗
- LifeVine Wellness — contact ↗
- LifeVine Wellness — weight loss ↗
- LifeVine Wellness — consumer health data privacy ↗
- LifeVine Wellness — how it works ↗
- LifeVine Wellness — tirzepatide ↗